These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15173818)
21. Effects of Lugol staining on stenosis formation induced by radiofrequency ablation of esophageal squamous epithelium: a study in a porcine model. Schölvinck DW; Alvarez Herrero L; Visser M; Bergman JJ; Weusten BL Dis Esophagus; 2015 Oct; 28(7):603-11. PubMed ID: 24712765 [TBL] [Abstract][Full Text] [Related]
22. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD. Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682 [TBL] [Abstract][Full Text] [Related]
23. [Endoscopic screening for upper gastrointestinal second primary malignancies in patients with hypopharyngeal squamous cell carcinoma]. Tian JJ; Xu W; Lyu ZH; Ma JK; Cui P; Sa N; Cao HY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):292-295. PubMed ID: 29747255 [No Abstract] [Full Text] [Related]
25. High-definition endoscopy with iScan and Lugol's solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group. Rey JW; Deris N; Marquardt JU; Thomaidis T; Moehler M; Kittner JM; Nguyen-Tat M; Dümcke S; Tresch A; Biesterfeld S; Goetz M; Mudter J; Neurath MF; Galle PR; Kiesslich R; Hoffman A Dis Esophagus; 2016; 29(2):185-91. PubMed ID: 25515856 [TBL] [Abstract][Full Text] [Related]
26. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Freitag CP; Barros SG; Kruel CD; Putten AC; Dietz J; Gruber AC; Diehl AS; Meurer L; Breyer HP; Wolff F; Vidal R; Arruda CA; Luz LP; Fagundes RB; Prolla JC Dis Esophagus; 1999; 12(3):191-5. PubMed ID: 10631911 [TBL] [Abstract][Full Text] [Related]
29. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial. Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469 [TBL] [Abstract][Full Text] [Related]
30. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Dawsey SM; Lewin KJ; Liu FS; Wang GQ; Shen Q Cancer; 1994 Apr; 73(8):2027-37. PubMed ID: 8156507 [TBL] [Abstract][Full Text] [Related]
31. Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial. Qu JY; Li Y; Liu GQ; Li Z; Zhong N; Zhang MM; Li YY; Yu T; Lu XF; Li LX; Liu H; Qi QQ; Li YQ; Zuo XL J Gastroenterol Hepatol; 2023 Jun; 38(6):962-969. PubMed ID: 37094943 [TBL] [Abstract][Full Text] [Related]
32. Chromoendoscopy with iodine staining, as well as narrow-band imaging, is still useful and reliable for screening of early esophageal squamous cell carcinoma. Shimizu Y; Takahashi M; Mizushima T; Ono S; Mabe K; Ohnishi S; Kato M; Asaka M; Sakamoto N Am J Gastroenterol; 2015 Jan; 110(1):193-4. PubMed ID: 25567173 [No Abstract] [Full Text] [Related]
33. [Telomerase activity in esophageal carcinoma and lesions unstained with Lugol's solution]. Yoneyama K; Aoyama N; Koizumi H; Tamai S Nihon Rinsho; 1998 May; 56(5):1181-5. PubMed ID: 9613118 [TBL] [Abstract][Full Text] [Related]
34. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma. Khoshbaten M; Naderpour M; Mohammadi G; Alipoor SH; Estakhri R; Fazeli Z Asian Pac J Cancer Prev; 2010; 11(4):863-5. PubMed ID: 21133592 [TBL] [Abstract][Full Text] [Related]
36. Lugol chromoendoscopy for esophageal squamous cell cancer. Inoue H; Rey JF; Lightdale C Endoscopy; 2001 Jan; 33(1):75-9. PubMed ID: 11204992 [No Abstract] [Full Text] [Related]
37. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis. Chow TL; Lee DT; Choi CY; Chan TT; Lam SH Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420 [TBL] [Abstract][Full Text] [Related]
38. Endoscopic survey of esophageal cancer in a high-risk area of China. Lu XJ; Chen ZF; Guo CL; Li SS; Bai WL; Jin GL; Wang YX; Meng FS; Gao F; Hou J World J Gastroenterol; 2004 Oct; 10(20):2931-5. PubMed ID: 15378767 [TBL] [Abstract][Full Text] [Related]
39. High-definition endoscopy with i-Scan and Lugol's solution for more precise detection of mucosal breaks in patients with reflux symptoms. Hoffman A; Basting N; Goetz M; Tresch A; Mudter J; Biesterfeld S; Galle PR; Neurath MF; Kiesslich R Endoscopy; 2009 Feb; 41(2):107-12. PubMed ID: 19214887 [TBL] [Abstract][Full Text] [Related]
40. A syringe method for esophageal Lugol's iodine chromoendoscopy. Liu K; Bai J; Gao L; Dong X; Han Y; Liu Z Endoscopy; 2023 Dec; 55(S 01):E1256-E1257. PubMed ID: 38128594 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]